DENNIS ROTONDI: Open Payments
NPI 1487326245 · PROVIDENCE, RI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,785 in 73 payments from 15 companies in 2025. Trend: 2023 $1,380 · 2024 $1,854 · 2025 $1,785
Food & beverage: $1,765Education: $20
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 14 | $306 |
| ABBVIE INC. | 13 | $267 |
| Ardelyx, Inc. | 12 | $263 |
| Gilead Sciences, Inc. | 7 | $221 |
| Janssen Biotech, Inc. | 6 | $190 |
| Phathom Pharmaceuticals, Inc. | 4 | $113 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $105 |
| Madrigal Pharmaceuticals | 3 | $94 |
| Intercept Pharmaceuticals, Inc. | 2 | $59 |
| Braintree Laboratories, Inc. | 2 | $55 |
Products named: XIFAXAN, IBSRELA, TREMFYA, CREON, VOQUEZNA, ENTYVIO, REZDIFFRA, OCALIVA.
Industry payments across RI — which companies pay providers there.
